Gyros Protein Technologies
Gyros Protein Technologies introduces Gyrolab Generic Rodent ADA Kit Reagents to support preclinical immunogenicity assessment
Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in rodent samples 2 May 2024 — Uppsala, Sweden — Gyros Protein Technologies, a pioneer in automated nanolitre-scale immunoassays and a leading provider of peptide synthesisers and reagents, today announced the introduction of Gyrolab Generic Rodent Anti-Drug Antibody (ADA) Kit Reagents…
Gyros Protein Technologies establishes dedicated office in Japan
Pioneer in automated nanoliter-scale immunoassays announces the establishment of a Tokyo office
Gyros Protein Technologies Appoints Frank Witney as Chairman
Automated nanoliter-scale immunoassays company today announced the appointment of a new Chairman of the Board

